Target intelligence / Profile preview

Fascin actin-bundling protein 1 messenger RNA (FSCN1 mRNA) (FSCN1 mRNA)

Target
FSCN1 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Fascin actin-bundling protein 1 (FSCN1) mRNA is the transcript encoding the Fascin-1 protein, which plays a pivotal role in organizing actin filaments into parallel bundles. These bundles are essential for the formation of filopodia and invadopodia, structures that drive cell motility and invasive behavior (UniProt P17677). While Fascin-1 is minimally expressed in normal epithelial tissues, its mRNA is significantly upregulated in various metastatic cancers, including breast, lung, and colorectal cancers, where it serves as a marker of poor prognosis (PubMed 30655540). Targeting the mRNA directly via RNA interference (RNAi) or antisense oligonucleotides (ASOs) allows for the knockdown of Fascin-1 protein production, effectively paralyzing the migratory machinery of cancer cells (PubMed 25661344). This approach has shown promise in preclinical studies for reducing tumor invasion and metastasis (PubMed 28813661). Current challenges in targeting FSCN1 mRNA include the development of efficient delivery systems to reach tumor cells and avoiding potential side effects in normal cells that express Fascin-1, such as mature dendritic cells (PubMed 22431510). By silencing the FSCN1 gene at the transcript level, researchers aim to provide a therapeutic strategy that complements existing treatments by specifically inhibiting the metastatic cascade.

Other names
Fascin-1 mRNAFAN1 mRNASNL mRNAp55 mRNAFascin actin-bundling protein 1 transcript
02

Mechanism of action

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to prevent translation of the Fascin-1 protein.

03

Biological functions

Protein translationRegulation of actin cytoskeletonCell migrationFilopodia formation
04

Disease associations

CancerBreast cancerColorectal cancerEsophageal squamous cell carcinomaPancreatic cancerLung cancerGastric cancer
05

Safety considerations

Off-target silencing of unintended genesDelivery to target tissuesPotential toxicity of delivery vehiclesImpact on normal cells expressing Fascin-1 such as dendritic cells and neurons
06

Interacting drugs

si-FSCN1

3 more in the full profile.

07

Biomarkers

FSCN1 mRNA expression levelsFascin-1 protein expression

Beyond the preview

Go deeper on Fascin actin-bundling protein 1 messenger RNA (FSCN1 mRNA) (FSCN1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fascin actin-bundling protein 1 messenger RNA (FSCN1 mRNA) (FSCN1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call